PT - JOURNAL ARTICLE AU - Gerard Bryan Gonzales AU - James M Njunge AU - Bonface M Gichuki AU - Bijun Wen AU - Isabel Potani AU - Wieger Voskuijl AU - Robert Bandsma AU - James A Berkley TI - Plasma proteomics reveals markers of metabolic stress in HIV infected children with severe acute malnutrition: call for more evidence-based nutritional intervention strategies AID - 10.1101/19006726 DP - 2019 Jan 01 TA - medRxiv PG - 19006726 4099 - http://medrxiv.org/content/early/2019/10/18/19006726.short 4100 - http://medrxiv.org/content/early/2019/10/18/19006726.full AB - HIV infection affects up to 30% of children presenting with severe acute malnutrition (SAM) in Africa and is associated with increased mortality. Children with SAM are treated similarly regardless of the presence of HIV although mechanisms of nutritional recovery in HIV and/or SAM are not well understood. We aimed to test the hypothesis that metabolic and inflammatory perturbations among children with SAM differed between those with HIV (n = 54) and without HIV (n = 113) to better understand their specific nutritional and therapeutic requirements. We performed a secondary analysis of a clinical trial and plasma proteomics data among children with complicated SAM in Kenya and Malawi. Compared to children with SAM without HIV, HIV-infected children had evidence (false discovery rate corrected p<0.05) of metabolic stress, including enriched pathways related to inflammation and lipid metabolism. Moreover, we observed reduced plasma levels of zinc-α-2-glycoprotrein, butyrylcholinesterase, and increased levels of complement C2 resembling findings in metabolic syndrome, diabetes and other non-communicable diseases. HIV was also associated (false discovery rate corrected p<0.05) with higher levels of plasma chemokines: MCP1, CCL4, GCSF, IL1b, TNFa, IL-2, 5, 7, 8 and 15, IL12p40, IP-10, and IL-1RA. Considering evidence of biomarkers of metabolic stress in children with HIV and SAM, it is of potential concern that our current treatment strategy for SAM regardless of HIV status involves a high-fat therapeutic diet. The results of this study indicate a need for clinical trials of therapeutic foods that meet the specific metabolic needs of children with HIV and SAM.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe original clinical trial was supported by the Thrasher Fund (grant number: 9403), awarded to JAB. GBG is a postdoctoral fellow of the Research Foundation - Flanders (FWO). The Ghent University -VLIR-UOS Global Minds Fund supported the travel of GBG to Kenya. JAB and JMN are currently supported by the Bill & Melinda Gates Foundation within the Childhood Acute Illness and Nutrition (CHAIN) Network (grant OPP1131320). JAB is currently supported by the MRC/DfID/Wellcome Trust Joint Global Health Trials scheme (grant MR/M007367/1). The funders had no role in the design, conduct, analysis, or writing of this manuscript.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesRequest for data access can be sent to KEMRI-Wellcome Trust via Prof James Berkley: JBerkley@kemri-wellcome.org. Data is currently not available in public repositories but the authors are currently in the process of obtaining permission to be able to make it publicly available.